CD4 and cholangiocarcinoma: Considering the importance of CD4+ Treg cells in inhibiting an effective antitumor immune response, we have quantified and investigated the function of this cell subset in the peripheral blood (PB) of CCA and HCC patients before tumor resection (T0) and once the patients were recovered from surgery (T1).